Company Badge
USPTO Data Jan 1 1976 - Nov 3 2026
6 Patents
#305 in Singapore
#305 in Singapore
Moleac Pte Ltd.
Forward Citations = 3
9 inventors:
Moleac Pte Ltd.
Calculating rank
% Expired Patents = 16.7
EPO Patents = 4
Trademarks = 2
Forward Citations = 3
Loading Chart...
Loading Chart...
9 inventors (with patents filed for the assignee):
David Picard (4 out of 4 patents)
Michel Maurice Jacques Lazdunski (2 out of 2 patents)
Catherine Louise Heurteaux (2 out of 6 patents)
4. Michael Lazdunski (2 out of 2 patents)
5. Kirti S Laddha (1 out of 1 patent)
6. Xue Min Shi (1 out of 1 patent)
7. Xuemin Shi (1 out of 1 patent)
8. Ji Sheng Han (1 out of 1 patent)
9. Shreeram Narahari Agharkar (1 out of 2 patents)
10. Hamid Moha Ou Maati (1 patent)
11. Michel Lazdunski (18 patents)
12. Catherine Louise Claude Heurteaux (0 patent)
6 patents:
Company Overview
Moleac is a biopharmaceutical company focused on discovering, developing, and commercializing neurorestorative medicines. With a mission to improve the quality of life for patients with neurological disorders, Moleac's innovative research and development efforts have led to breakthrough therapies that address unmet medical needs in the field of neurology.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Moleac Pte Ltd.. Retrieved from https://idiyas.com/company/moleac
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]